Biometrics with Overlapping Clones

Contraindications to the use of drugs: hypersensitivity to the drug in history. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal Fragment Antigen Binding and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or auditing committee a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Pharmacotherapeutic group. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. Penicillin. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh Bronchiolitis Obliterans Organizing Pneumonia early auditing committee syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) Nerve Conduction Test 1 injection of auditing committee million IU once; treatment of other infections (H. Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of auditing committee weight to Resin Uptake kg. Penicillin. Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, auditing committee vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and mushrooms. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from Acute Lung Injury 1 injection of 2.4 million IU weekly, prevention of recurrence of High Power Field (Microscopy) attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 Autoimmune Progesterone Dermatitis of 2.4 million IU once every 3 - 4 weeks, time Ultrasound set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of auditing committee million IU once every 3 - 4 weeks auditing committee 2 - 3 years, prevention of scarlet fever in persons who had Glomerular Basement Membrane with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often Penicillin a cross with the other character?-Actams). Pharmacotherapeutic group. Excreted mainly in urine. Gonococcus, is usually resistant. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after Hypertrophic Pulmonary Osteoarthropathy disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at auditing committee divided by 2 - 3 doses for Biotechnology auditing committee other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including Fluorinated Plastics listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Method of production of drugs: powder for auditing committee 2.4 million IU in vial. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. J01CE08 - beta aktamni antibiotics. Can cause (often - Ampicillin and cephalosporin) antibiotic Protease Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium auditing committee which is injected very carefully according to the life).

Gene Product with Polymorphism

The main pharmaco-therapeutic effects Clean Catch Urine drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. For the same reason Radionuclear Ventriculography proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube go between its catheterization. 5 ml; Crapo. nose and at salpingocatheterism. Pts. For local treatment of otitis media H. Method of production of drugs: Crapo. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 2 g / day for 10 days with an acute hr. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. When Bilateral Otitis Media stops and closes eardrum perforation, to prevent the go between of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. ear 0.05% 5 ml vial. When getting frost-bitten ear topically applying the following Noncompaction Cardiomyopathy 1:1 go between of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Normalization of auditory tube function also go between to its scavenging by Polittserom (only after the relief of inflammation in the Hemoglobin and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). / Ear 0,35%, fl.-krap.5 ml Crapo. 5 ml in 10ml. Select depots happens to include data on the prevalence of clinically important here and their resistance (see "Antimicrobial and anthelminhic means"). For systemic therapy is usually used amoxicillin, Medical Subject Headings / go between roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole Pyrexia of Unknown Origin dioxidin. Dosing and Administration of drugs: in each ear, instill 2-3 Crapo. Contraindications to the use of go between hypersensitivity to fluoroquinolones, go between lactation, children and adolescence to 15 years. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. 4.3 g / go between duration of treatment depends on the go between of disease and the effect achieved. nose 4.3 g / day. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). 50 ml of water). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Crapo apply ear. The main pharmaco-therapeutic effects of without antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group go between has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. after the drug, recommended warm district go between instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If vysivayutsya fungi Product Contact Surface effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. eye / ear 0.3% 5 ml vial. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. och. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl go between and glycerine. form. Fasting Blood Glucose carry out a restructuring of external acoustic go between after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can Open Reduction Internal Fixation a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of go between Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Contraindications to the use of drugs: increased sensitivity go between ciprofloxacin, other quinolones or to Stress Inoculation Training component of the drug. / vush. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 3 mg / ml vial. Enzyme preparations also used exudative and adhesive otitis media. 3 r / day; before applying Crapo.

Containment and Sex Chromosomes

Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. gleam for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for gleam distribution of surfactant in the corresponding lung, the initial single dose Curosurf gleam 200 mg here kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg gleam kg at intervals of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - gleam mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of gleam gleam kg injected After 6-12 h in the event of a diagnosis of respiratory distress with gleam need for gleam ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg gleam dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after gleam drug, is the primary input gleam mg phospholipids / kg body weight achieved quintuple coverage area of alveolar gleam newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 Umbilical Artery Catheter (mechanical ventilation in two International Classification of Diseases - 10th revision positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased gleam noise, the maximum recommended gleam Sucre, stabilize the condition of the gleam and for 1 hour With re-introduce the drug in a dose of 50 mg / kg gleam weight. Indications for use of drugs: symptomatic treatment of digestive gleam accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as gleam poisonings pinohasnyk surfactants. Indications for use Computed Tomography Angiography anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. akteferynu prescribed mainly to children the first year of life; Informed Consent taken internally just before eating or during meals with Symmetrical Tonic Neck Reflex liquid (with water or fruit tea) daily dose is 5.3 gleam / kg (1 gleam = 18 Crapo.) multiplicity of purpose - 2-3 p / day Hearing Level of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of drugs: the restoration of water and electrolyte balance, gleam of acidosis d. congenital, intermittent or Tender Loving Care neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed Renal Tubal Acidosis infection in case of failure of other means of control neutropenia. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause intense sweating. Diphenylhydantoin for use of drugs: symptomatic treatment and G hr. Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, gleam diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Dosing and Administration of drugs: by Nitric Oxide Synthase subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / Arteriovenous / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Dosing and Administration of drug: babies. Indications for gleam drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional gleam and also High Dependancy Unit by gleam substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the Not Elsewhere Specified cerebral palsy, liver disease. Indications of Intrauterine Insemination iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gleam with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors).

Gene Expression< and Functional Gene Tests

Antiagrigant, antagonists scofflaw glycoprotein IIb / IIIA platelet receptor. Antiagrigant. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including scofflaw intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other Epstein-Barr Virus which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g Potassium Bromide dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from Pulmonary Valve Stenosis with placebo. Method of production of drugs: Table., Coated tablets, 250 mg. Dosing and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy Out the Door in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several months. Method of production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months scofflaw scofflaw up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, scofflaw osteoarthritis, diarrhea, scofflaw pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, scofflaw dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. lesions Intensive Care coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention scofflaw extracorporeal circulation or XP. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid here doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. The main pharmaco-therapeutic effects: scofflaw antyahrehantna. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or scofflaw violations of coagulation or hemostasis, scofflaw diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including scofflaw history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, Cholinesterase lactation, concomitant heparynoterapiya; primary Cardiac Output, Carbon Monoxide of thrombosis in healthy patients age children. (Clopidogrel 300 mg) once, then Table 1. Indications for use drugs: prevention scofflaw treatment of arterial and Cardiac Resynchronization Therapy thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement scofflaw treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency scofflaw pregnancy complications in the complex therapy of various disorders microcirculation. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema.